Braidwell »

Relay Therapeutics shares owned by Braidwell

Quarter-by-quarter ownership of Relay Therapeutics (RLAY) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Relay Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relay Therapeutics held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relay Therapeutics by Braidwell

Quarter filed Position value Share count Share price at filing
2024-03-31 $31M 3.7M 8.30

More positions owned by Braidwell

Guardant Health Note11/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Exact Sciences Corp Note 0.375% 3/0 (Principal)
Novocure Note11/0 (Principal)
Apogee Therapeutics (APGE)
Nuvasive Note 0.375% 3/1 (Principal)
Neurocrine Biosciences (NBIX)
Argenx Se Sponsored Adr (ARGX)
Vaxcyte (PCVX)
Neogenomics Note 0.250% 1/1 (Principal)
Dexcom Note 0.250%11/1 (Principal)
Legend Biotech Corp Sponsored Ads (LEGN)
Insmed Note 1.750% 1/1 (Principal)
Insulet Corp Note 0.375% 9/0 (Principal)
Penumbra (PEN)

View all positions for Braidwell

Top funds holding Relay Therapeutics

Vanguard Group
BlackRock
Casdin Capital
T. Rowe Price Associates
Bellevue Group
Arrowpoint Asset Management
Nextech Invest
Braidwell
Jpmorgan Chase & Co
Geode Capital Management
Boxer Capital
Goldman Sachs Group
Jacobs Levy Equity Management
Dimensional Fund Advisors
Alphabet

View all funds holding Relay Therapeutics